VIVIENNE TAYLOR: Open Payments
NPI 1861464372 · ROME, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$687 in 29 payments from 14 companies in 2025. Trend: 2023 $80 · 2024 $237 · 2025 $687
Food & beverage: $687
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 4 | $174 |
| Madrigal Pharmaceuticals | 3 | $108 |
| PFIZER INC. | 4 | $85 |
| AstraZeneca Pharmaceuticals LP | 4 | $67 |
| Novo Nordisk Inc | 3 | $59 |
| Exact Sciences Corporation | 2 | $32 |
| Phathom Pharmaceuticals, Inc. | 2 | $30 |
| Dexcom, Inc. | 1 | $27 |
| Axsome Therapeutics, Inc. | 1 | $24 |
| Otsuka America Pharmaceutical, Inc. | 1 | $18 |
Products named: AREXVY, REZDIFFRA, SHINGRIX, Wegovy, BREZTRI, ELIQUIS, Cologuard Collection Kit, VOQUEZNA.
Industry payments across NY — which companies pay providers there.
